Skip to main content

Kanecia Obie Zimmerman

Wilburt C. Davison Distinguished Professor
Pediatrics, Critical Care Medicine
300 West Morgan Street, Durham, NC 27710

Research Interests


Pharmacoepidemiology
Clinical Pharmacology
Drug Safety in Pediatric Critical Illness

Selected Grants


Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029

North Carolina Community Schools Coalition (NCCSC)

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Department of Education · 2024 - 2028

NICHD Pediatric and Maternal Resource Center: Bridging Pharmacology and the Real World

ResearchPD/PI · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2028

Stimulating Access to Research in Residency (StARR) - NHLBI

Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028

Equity-Focused Communication Intervention for Family-Centered Rounds

ResearchCo-Mentor · Awarded by National Institutes of Health · 2024 - 2027

2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2021 - 2026

Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials (IMPACCT)

ResearchPrincipal Investigator · Awarded by Ann & Robert H Lurie Children's Hospital of Chicago · 2021 - 2026

PTN 2.0 TO #11: CUDDLE 2.0

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2026

Pediatric Trials Network_ Task Order 1_ Core Function Activities

ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2026

PTN 2.0 Task Order 7 HIV Lactation

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2025

Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and your Children (COA APTIC)

ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2019 - 2025

PTN LAP01 Registry

ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2021 - 2025

PTN Task Order 8 COVID-19 Studies

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2025

PTN TO# Anesthesia

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2025

Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2025

RECOVER Infrastructure Modification 11 (Yr 3)

ResearchPrincipal Investigator · Awarded by Research Triangle Institute International · 2022 - 2025

Duke Summer Training in Academic Research (Duke's STAR) BIOGEN

ResearchPrincipal Investigator · Awarded by Biogen Foundation · 2022 - 2025

PTN 2.0 TO 5 Modification

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

PTN TO: BPCA INNOVATIVE TRIAL DESIGNS FOR DOSING, SAFETY, and EFFICACY in PEDIATRIC THERAPEUTICS

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

Duke Summer Training in Academic Research (Duke's STAR)

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2024

Unified Program for Therapeutics in Children

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2024

Optimizing caffeine exposure to reduce post-cardiopulmonary bypass acute kidney injury in neonates

ResearchPrincipal Investigator · Awarded by Thrasher Research Fund · 2022 - 2023

Duke Summer Training in Academic Research (Duke's STAR) BIOGEN

ResearchPrincipal Investigator · Awarded by Biogen Foundation · 2021 - 2023

Bridging the Gap to Enhance Clinical Research Program (BIGGER)

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2016 - 2023

PTN2- TO# BPCA Pharmacology Studies

ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2023

PTN 2.0 TO1 Core Function Activities - Option 4

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2022 - 2023

Pediatric Critical Care Research Landscape - A National Expert Conference

ConferenceCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2022

PTN TO48 - Pharmacokinetics of Anesthetics and Analgesics in Children and Adolescents Extension

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2022

PTN 2.0 TO 1 Core Function Activities_Option 3.1

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2022

Investigating polypharmacy-related adverse events in critically ill children using electronic health records and simulated drug levels

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2021

IMPACCT

ResearchPrincipal Investigator · Awarded by Ann & Robert H Lurie Children's Hospital of Chicago · 2019 - 2021

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021

PTN 2.0 TO 1 Core Function Activities_Option 2

Clinical TrialCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2021

Prospect of Direct Benefit in Pediatric Reseach in Type 1 Diabetes (T1D)

ResearchPrincipal Investigator · Awarded by Juvenile Diabetes Research Foundation · 2018 - 2021

Pediatric Trials Network_ Task Order 1_ Core Function Activities Option Period 1

ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2019 - 2020

Oxycontin Drug Utilization in Children

Clinical TrialPrincipal Investigator · Awarded by Purdue Pharma · 2019 - 2019

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2017 - 2019

Duke CTSA (KL2)

ResearchScholar · Awarded by National Institutes of Health · 2013 - 2018

External Relationships


  • Student U

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.